Resident Review
TIME AND DATES:
Friday, October 16th from 1:00 pm until 5:40 pm in the Hill Country Ballroom.
PURPOSE:
The resident review session was founded in 2005 by Drs Craig Clifford and Barbara Kitchell. Its purpose is to provide an avenue for further learning in a variety of oncology based disciplines for residents in both the academic and private practice setting. The program was altruistically created as a way for those who have completed their training to “give back” to those currently in residency programs. The review sessions rotate through pivotal oncology based topics in the form of lectures given by experts in their respective fields of veterinary oncology.
Since its inception the review session has grown tremendously and is sanctioned by VCS and fully sponsored. The resident review session is not paramount for board preparation but is more designed to provide supplemental lectures for residents.
GUEST SPEAKERS:
Featured Speaker: Cheryl London
Tyrosine Kinase Dysfunction and Targeted Therapeutics
Cheryl London DVM, PhD completed her veterinary training at Tufts University College of Veterinary Medicine in 1990. She then was in private practice in Kennebunk, Maine for 2 years before completing a residency in Medical Oncology at the University of Wisconsin-Madison. Dr. London is a board-certified diplomat of the American College of Veterinary Internal Medicine (Oncology). Following this clinical specialization Dr. London received a PhD in Immunology from Harvard University and was a post-doctoral fellow at the Brigham and Women’s Hospital in Boston. Dr. London received a K01 award to support her graduate training at Harvard. After completing her graduate work in 1999, Dr. London joined the faculty at the UC Davis School of Veterinary Medicine as an Assistant Professor. In 2005, she moved to The Ohio State University where she is currently an Associate Professor and the endowed Shackelford Professor of Veterinary Medicine. Dr. London is also the Director of the Clinical Trials Office at OSU, and a member of the Clinical Translational Science Award Program. Dr. London maintains an active laboratory at OSU investigating the molecular biology of various canine cancers in an effort to identify new targets for therapeutic intervention. She is currently mentoring three PhD candidates, all veterinarians who are in combined graduate/residency programs.
Featured Speaker: Dr. Chand Khanna
Metastasis Biology and Therapy
Chand Khanna DVM, PhD completed his veterinary training at the Western College of Veterinary Medicine in 1991. He then received specialty training in the fields of veterinary internal medicine and oncology first at the Ontario Veterinary College, University of Guelph and then the University of Minnesota. Dr. Khanna is a board-certified diplomat of the American College of Veterinary Internal Medicine (Oncology). Following this clinical specialization Dr. Khanna received a PhD in Pathobiology from the University of Minnesota and then post-doctoral fellowship at the National Cancer Institute in Bethesda Maryland.
Dr. Khanna is currently Head of Pediatric Oncology Branch’s Tumor and Metastasis Biology Section, and Director of the Center for Cancer Research, Comparative Oncology Program at the National Cancer Institute. His research interests and responsibilities are focused on the problem of cancer metastasis and the development of new options to treat patients with metastasis. Dr. Khanna combines his love for clinical medicine with his motivation to improve outcomes for cancer patients through his referral oncology practices, The Oncology Service, based in the greater Washington DC area.
Dr. Khanna is the President Elect of the American College of Veterinary Internal Medicine, an associate editor for the Journal of Veterinary Internal Medicine and the Journal of Veterinary and Comparative Oncology. Dr. Khanna is the chair of the Children’s Oncology Groups Bone Biology Subcommittee and the Comparative Models Subcommittee. Dr. Khanna is a founding member of the Canine Comparative Oncology and Genomics Consortium.